Jack Khattar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTimothyc decPeter vozzoJacka khattarJack khattarSupernus pharmaceuticalsExchange commissionMarriott marquis hotelSecurities exchangeSupernus pharmaceuticals incJefferies global healthcare conferenceInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

Supernus Pharmaceuticals to Participate in the Jefferies

Supernus Pharmaceuticals to Participate in the Jefferies
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTimothyc decJacka khattarPeter vozzoJack khattarSecurities exchangeSupernus pharmaceuticals incMarriott marquis hotelExchange commissionSupernus pharmaceuticalsJefferies global healthcare conferenceInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc decPeter vozzoJack khattarJacka khattarDrug administrationSupernus pharmaceuticals incSupernus pharmaceuticalsExchange commissionCompany investor relationsSecurities exchangeAnnounces promising interim dataOngoing open label phaseInvestor relationsOrphan drugDravet syndromeLennox gastaut syndrome

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Tim decPeter vozzoJack khattarSupernus pharmaceuticals incSupernus pharmaceuticals first quarterBiggest oil producing countries in asiaSupernus pharmaceuticalsCall transcript mayResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officerChief financial officerRisk factorsCelebrities actually wearOil producing countries

FDA Decision on Apomorphine Infusion Device Delayed Again

The drug/device combination therapy provides a continuous subcutaneous infusion of apomorphine through an infusion pump. The FDA has issued a Complete Response Letter to Supernus Pharmaceuticals regarding the New Drug Application for SPN-830.

Jack khattarDrug administrationSupernus pharmaceuticalsComplete response letterNew drug application